DOC
SLIDES
Featured
Recent
Articles
Topics
Upload
Login
Sign Up
Featured
Recent
Articles
Topics
Upload
Login
Sign Up
Home
›
Search Results for "patients peg"
Search Results for 'patients peg'
patients peg published presentations and documents on DocSlides.
Long Term Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Chronic Gout: The Fe
by jaena
MacDonald T, et al. . Long Term Cardiovascular Saf...
How to optimize treatment of G1 patients?
by KissesForYou
Prof. G. K. K. Lau 2012. Standard of care (SOC) ...
Updates in Treatment of Hepatitis C
by cheryl-pisano
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Updates in Treatment of Hepatitis C
by myesha-ticknor
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Systemic treatment for
by BubblyBlonde
breast cancer brain . metastases: . New . options ...
Percutaneous Endoscopic Gastrostomy Four Years
by anderson
171 of Experience of General Surgery Department at...
Original ArticlePercutaneous endoscopic gastrostomyA secondary care h
by lam
Muhammer Ergenç, Serhat Tolga Derici, Introducti...
SOF + RBV
by debby-jeon
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
M.W. Fried , 1 M. Buti,
by iamamercy
2. G.J. Dore,. 3. P. Ferenci,. 4. . I. Jacobson...
PRESS RELEASE
by olivia
Stockholm, Sweden, 27 October 2020 Sobi and Apel...
Pegvisomant (DB00082 ) Approved
by Lionheart
Drug. Chemical Formula: . C. 990. H. 1532. N. 262....
ercutaneous Endoscopic Gastrostomy
by murphy
PAT/ T 16 v.4 Page 1 of 21 P (P EG ) / Enteral ...
Management of HCV in Co-Infected Patients
by danika-pritchard
Marie-Louise Vachon, MD, . MSc. Division of . Inf...
Practical management of PI therapy
by TropicalParadise
in Hepatitis C . Paris . Februari. 2012. Ola . We...
Consensus Statement on acromegaly
by stella
. therapeutic outcomes. ...
Hepatitis C: A New Era In Treatment And Cure
by myesha-ticknor
Adam . Deising. , DO. LCDR MC USN. Director of . ...
Reduction in Ischemic Events with
by natalia-silvester
Ticagrelor. in Diabetic Patients from the PEGASU...
Resistance to Direct Acting Antiviral Therapy
by tawny-fly
Resistance to HCV DAAs: What is the threat level...
Long-Term Tolerability of
by briana-ranney
Ticagrelor. for Secondary Prevention: . Insights...
Out With the Old and In With the New, Again?
by test
Out With the Old, In With the New. Current Standa...
Boceprevir
by tatyana-admore
for Patients with Prior Failure to PEG + RIB. PRO...
Direct Acting Antivirals: What are they? What is their pl
by tawny-fly
Mark Sulkowski, MD. Associate Professor of Medici...
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
Current strategies for the management of treatment naïve a
by min-jolicoeur
Mark S. Sulkowski, MD. Medical Director, Viral He...
Case Report: Nutritional Management of a Critically Ill HIV
by test
Stephanie Yednak. Disease Description. HIV causes...
P rognosis
by liane-varnes
Life expectancy from the time of diagnosis: . Alz...
Sofosbuvir + Peginterferon + Ribavirin in Genotype 2
by debby-jeon
. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...
W. David Clark, MD November 18, 2015
by pasty-toler
Nutrition Considerations in Advanced Dementia. Di...
Sweet or Sour? The Future of Diabetes Treatment
by alida-meadow
Dana Staat, . PharmD. Clinical Pharmacy Lead-Inte...
What Has Been Tried and What Is True?
by celsa-spraggs
What Has Changed?. Less Stent Thrombosis . With. ...
HIV-HCV Coinfection in the era of effective antiviral therapy
by mia
Mark Sulkowski, . MD. Professor of Medicine. Medic...
Are (exogenous) interferons
by amey
really necessary?. Peter . Ferenci. Medical Univer...
FISSION Design Objective
by travis
Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...
Load More...